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Abstract
Background: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the
gastrointestinal tract and liver and peritoneum are the main sites of recurrence. Ovarian metastases from GIST are
very rare.
Case Presentation: A 50 years-old woman was found to have a pelvic mass on transvaginal ultrasound (TV-US)
and computed tomography (CT)-scan, considered as a right ovarian mass. The patient underwent surgical
abdominal exploration that showed an ileal mass, a normal right ovary and an irregular and vascularized surface of
the left ovary. A segmental ileal resection and an ileal anastomosis were performed. Frozen section showed a GIST
and surgery was completed with hysterectomy, bilateral salpingo-oophorectomy, pelvic peritonectomy, peritoneal
washing and Burch procedure. The histological examination confirmed an ileal GIST with ovarian metastases,
harboring in both sites of disease a KIT exon 11 deletion.
Conclusions: Ovarian localizations, as far as rare, can be a clinical finding in case of ileal GIST patients, and both
gynecologists, pathologists and medical oncologists should be able to recognize them.
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Background
Gastrointestinal stromal tumors (GIST) are the most fre-
quent mesenchymal tumors of the gastrointestinal tract,
commonly occurring in the stomach (60%), followed by
the small bowel (35%) and other sites (colon, rectum,
and esophagus < 5%) [1]. Nevertheless, they are consid-
ered rare, with an incidence in Europe of 1.5 new cases
per million per year.
As is well known, the liver and peritoneum are the most
frequent site of metastases, both as synchronous and
metachronous presentation [2]. Even if more rarely, also
lung and bone metastases can occur during the disease
course [3, 4]. In the past years, other anecdotal sites of
GIST recurrences have been reported in single cases [5–8].
To our knowledge, ovarian metastases from GIST have been
previously described only in five cases in a series [9].
Herein we report a case of GIST patient presenting
bilateral ovarian metastases at the onset of disease, highlight-
ing the pathological/molecular features of this unusual site
of metastatic presentation and the clinical implications.
Case Presentation
A 50 years-old woman, G1P1 was referred to gynecological
consultation for uterine prolapse. Her medical history was
positive for a spinal schwannoma, surgically removed the
year before and her family history was negative for cancer.
Transvaginal ultrasound (TV-US) showed a solid hypoe-
choic pelvic mass, with irregular margins, vascularized to
power Doppler (color score 3), not fixed to surrounding
structures (Fig. 1a). Because of the site and the proximity
to the ovarian vessels it was considered as a right ovarian
mass of 54 × 37 mm of diameter. Left ovary appeared
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normal except to two small anechoic images (< 1 mm)
mimicking ovarian follicles (Fig. 1b). The subsequent
computed tomography (CT)-scan evaluation confirmed
the presence of an expansive right adnexal lesion, with
lobulated margins and heterogeneous enhancement on
post-contrast CT images (Fig. 2). The woman was
counseled to perform hysterectomy and bilateral salpingo-
oophorectomy with intraoperative frozen section on right
adnexa and simultaneous correction of prolapse with
laparoscopic access. Thus, the patient underwent surgery.
Laparoscopic abdominal exploration showed a round
shaped, reddish, easily bleeding mass that originated from
one ileal loop displaced in the pelvis. Right ovary was
normal and covered by the mass, left ovary presented a
normal volume but an irregular and vascularized surface
and a round shaped, reddish, exophytic vegetation of 1 cm
of diameter originated from the ovarian surface. Small
nodules with similar appearance of the pelvic mass
suspected for diffusion of disease were showed in the peri-
toneum of the pouch of Douglas (Fig. 3a and b).
In consideration of the size and the uncertain nature of
the mass, of the suspicion of peritoneal diffusion, the sur-
geon decided to carry out a laparotomy. The explorative
laparotomy shows that others peritoneal surfaces and
organs were free from disease and no enlarged retroperi-
toneal lymph nodes were detected. Patient was submitted
to removal of the mass with ileal loop resection and ileal
anastomosis without stoma. Frozen section showed a
GIST. Surgery was completed with hysterectomy, bilateral
salpingo-oophorectomy, pelvic peritonectomy, peritoneal
washing and Burch procedure. At macroscopic examin-
ation, the pathological examination revealed an ileal
tumor mass measuring 7 × 5 × 5 cm and both ovaries
showed two bilateral nodular lesions of 2 cm and
0.5 cm, respectively. The ileal mass was solid, soft,
pink-tan tissue with areas of hemorrhage. Microscopic
examination of the small bowel tumor showed circum-
scribed proliferation of intersecting fascicles of spindle
cells with moderate atypia. Mitoses numbered 19 per
50 High Power Field (HPF); occasional atypical mitotic
figures were noted. Immunohistochemistry showed
strong and diffuse positivity for DOG-1 and c-kit lead-
ing to the diagnosis of GIST. The ovarian nodules,
grossly yellowish, solid, with circumscribed borders,
were composed, on microscopy, by a proliferation of
stromal spindle cells arranged in short fascicles, with
pale, occasionally vacuolated eosinophilic cytoplasm
Fig 1 a The solid and hypoechoic pelvic mass detected at trans-vaginal ultrasound. b Ultrasonographic aspect of left ovary
Fig. 2 CT scan image. The single star shows the pelvic mass
Fig 3 The laparoscopic pictures show the pelvic mass originating
from the ileum and the exophytic vegetation (single star) of the left
ovary that resulted a GIST metastasis at final microscopic examination
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and mild atypia. Considering the coexisting ileal GIST,
immunohistochemical stains for DOG-1 and c-kit were
also performed resulting strongly and diffusely positive.
The uterus was unremarkable. Cytology from peritoneal
washing was negative. The final diagnosis was GIST
(spindle cell type) of small bowel with bilateral ovarian
metastases (Fig. 4a, b, c, d) [10].
Molecular analysis performed on the primary tumor by
direct Sanger sequencing revealed a KIT exon 11 c-
1653_1670del mutation, with a consequent p.M552_W557
deletion. Then we performed the mutational analysis on all
sites of disease, including the left ovary lesion, confirming
the same KIT exon 11 deletion of the primary, without
secondary mutations.
The patient was referred to the GIST Study Group of
our Institution for an appropriate clinical management
and follow-up. A daily treatment with imatinib at the
standard dose of 400 mg was then started, with a sur-
veillance program by CT-scan every 4 months. At the
last follow-up the patient is still alive and free of disease
(Additional file 1).
Discussion and conclusions
The most common metastatic sites of GIST are the liver
and the peritoneum [2]; more rarely bone and lung can
occur [3, 4]. Ovarian metastases are exceptionally rare
and have been previously described only in five cases [9].
Herein we reported a case of GIST patient, presenting
ovarian metastases at the onset of disease. Given the rar-
ity of this unusual presentation, we retrospectively
reviewed the clinical cases of our institutional reference
center for GIST and among 224 female patients col-
lected from 2001, we found only another case of GIST
patient with synchronous ovarian metastases who was
managed at the time of diagnosis in another center.
GIST primary site was the ileum in both cases and the
ovarian localizations were multiple and of small dimen-
sion, ranging to 0,5 cm to 2 cm of diameter. Similarly,
the ovarian nodules, grossly yellowish, solid, with cir-
cumscribed borders, were composed on microscopy by a
proliferation of stromal spindle cells arranged in short
fascicles, with pale, occasionally vacuolated eosinophilic
cytoplasm and mild atypia (Fig. 4a, b, c, and d). A KIT
exon 11 c.1674_1695del mutation with a consequent
Lys558_Gly565 deletion was found by direct Sanger
sequencing [10].
Taken together, in addition to the unusual clinical
presentation, these cases may raise some cues of discus-
sion that may be relevant in clinical practice. From a
pathological point of view, gross examination showed
Fig. 4 a Ileal GIST, Hematoxylin and Eosin (H&E) stain, original magnification × 200. b Left ovary, Hematoxylin and Eosin (H&E) stain, original
magnification × 20. c Left ovary, Hematoxylin and Eosin (H&E) stain, original magnification × 400. d Left ovary, DOG-1, original magnification × 100
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different appearances of primary GIST and ovarian
localization. The ileal mass had the common macro-
scopic features of a GIST, but the ovarian lesions exhib-
ited yellowish color and circumscribed borders suggesting
a fibroma/thecoma. Although the microscopic features
were similar in ileal and ovarian lesions, considering the
unusual pattern of spread, differential diagnostic consider-
ations should be made. The diagnosis of benign or malig-
nant spindle cell tumor, primary or metastatic from the
uterus or other non-genital tract site, should be initially
considered. The differential diagnosis included benign
or malignant ovarian stromal tumors (e.g. fibroma, the-
coma, fibrosarcoma), granulosa cell tumor with fibro-
matous stroma, localization of leiomyoma or metastasis
of sarcoma (e.g. leiomyosarcoma, endometrial stromal
sarcoma). In order to establish the correct diagnosis,
accurate macroscopic and microscopic examination
and appropriate immunohistochemistry are crucial.
Regarding the kinase genotype, both cases harbor a
KIT exon 11 mutation, that represents the most com-
mon molecular event of GIST [11]. Of note, in both
cases the kind of mutation is an exon deletion, that it is
already known to correlate with a poorer clinical out-
come, if compared to insertion or point mutation muta-
tions, in line with the metastatic presentation of both
cases [12].
From a radiological point of view, the routine
gynecological exam by TV-US was at first apparently
negative. Left ovary was described with normal fea-
tures and some ovarian follicles and pelvic mass was
misdiagnosed as right ovary. In the light of the patho-
logical examination, US-images were thus revised and
subtle differences between ovarian follicles and ovarian
metastases from GIST were found. Both are round-
shaped and have similar dimension (5–10 mm) but the
first are totally anechoic, while the second are hypoechoic
without abnormal vascularization at power doppler (color
score 2). Compared to ovarian metastases from other pri-
mary cancers, accounting for about 16% of all ovarian
malignancies, some radiological differences can be found.
As is well known, ovarian metastases can arise from both
non-gynecologic tumors, as colon cancer (30%), stomach
(16%), appendix (13%), breast (13%), pancreas (12%) and
biliary tract (15%) cancers, and gynecologic tumors as
uterus (23%) and cervix (4%) cancers [13]. Ovarian metas-
tases from gastric, breast and uterus cancers appear as
solid masses at TV-US and a typical feature is the pres-
ence of a leading central vessel, while those from colorec-
tal and biliary tract cancers are more heterogeneous and
often they appear as multilocular solid masses [14].
Conversely, as far as we know, ovarian metastases from
GIST tend to have different US features. In particular,
GIST ovarian metastases seem to be multifocal and lo-
cated on the ovarian surface, while metastases from other
carcinomas are deeper. However, more data on US aspects
of ovarian metastases from GIST should be collected, in
order to better recognize them during both pre-operative
work up and during follow up of GIST patients. The role
of CT-PET scan in this setting should be explored, even if
the small size of the lesions may reduce the sensitivity,
specificity, and accuracy of this exam for detecting meta-
static ovarian lesions from GIST [15].
In conclusion, ovarian localizations, as far as rare, can
be a clinical finding in case of ileal GIST patients, and
both gynecologists, pathologists and medical oncologists
should be able to recognize them. Given the low accur-
acy of CT-scan for detecting small ovarian lesions, due
to their cystic pattern, a TV-US may be considered as a
pre-operative exam for all female patients affected by
ileal GIST, in order to exclude synchronous metastases,
and also during the follow up, especially in case of
doubtful ovarian findings. Finally, in case of clinical and
macroscopic suspect of metastasis in the ovaries and, of
course, taking into account the age of the patient, a
wider radical gynecological surgery may be considered.
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